Search
Search Results
##search.searchResults.foundPlural##
-
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3503PDF: 835HTML: 6696 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1217PDF: 514HTML: 22996 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2434PDF: 818HTML: 8790Efremov 1: 205Efremov 2: 165 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
976PDF: 975HTML: 87 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6759PDF: 3835HTML: 24850 -
Acquired Hemophilia A successfully treated with rituximab
1851PDF: 1096HTML: 1443Figure 1: 151 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1872PDF: 707HTML: 681 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3625PDF: 1208HTML: 3863Untitled: 190Untitled: 241 -
How I treat acute and persistent sickle cell pain
1843PDF: 1088HTML: 465 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3175PDF: 1191HTML: 8083 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1693PDF: 502HTML: 16959Figure 4: 144Figure 3: 125Figure 2: 124Figure 1: 154 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1132PDF: 806HTML: 3345 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1557PDF: 767HTML: 1219Figure 1: 152Figure 2: 168Figure 3: 165 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1977PDF: 1463HTML: 259 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
808PDF: 477HTML: 1286 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1245PDF: 775HTML: 114 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2000PDF: 904HTML: 280 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1216PDF: 880HTML: 280 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2323PDF: 889HTML: 486 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2811PDF: 1314HTML: 3551Untitled: 172Untitled: 186Untitled: 162 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
5946PDF: 3128HTML: 8989Figure Malaria Ricci: 208 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1028PDF: 525HTML: 1676Figures: 148Fifures Sanz: 157tables Sanz: 163Untitled: 158 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3960PDF: 1895HTML: 5193Table 1: 166 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
1204PDF: 945HTML: 312 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3162PDF: 1300HTML: 4106







